Cargando…

Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms

BACKGROUND: Gastric-cancer is a heterogeneous type of neoplastic disease and it lacks appropriate therapeutic options. There is an urgent need for the development of innovative pharmacological strategies, particularly in consideration of the potential stratified/personalized treatment of this tumor....

Descripción completa

Detalles Bibliográficos
Autores principales:	Guarrera, Luca, Kurosaki, Mami, Garattini, Silvio-Ken, Gianni’, Maurizio, Fasola, Gianpiero, Rossit, Luca, Prisciandaro, Michele, Di Bartolomeo, Maria, Bolis, Marco, Rizzo, Paola, Nastasi, Claudia, Foglia, Marika, Zanetti, Adriana, Paroni, Gabriela, Terao, Mineko, Garattini, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638833/ https://www.ncbi.nlm.nih.gov/pubmed/37951921 http://dx.doi.org/10.1186/s13046-023-02869-w

Ejemplares similares

All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon Responses and Antigen Presentation in Breast-Cancer Cells
por: Bolis, Marco, et al.
Publicado: (2020)

Role of cardiolipins, mitochondria, and autophagy in the differentiation process activated by all-trans retinoic acid in acute promyelocytic leukemia
por: Gianni’, Maurizio, et al.
Publicado: (2022)

A DOCK1 Gene-Derived Circular RNA Is Highly Expressed in Luminal Mammary Tumours and Is Involved in the Epithelial Differentiation, Growth, and Motility of Breast Cancer Cells
por: Kurosaki, Mami, et al.
Publicado: (2021)

MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells
por: Fisher, James Neil, et al.
Publicado: (2015)

Retinoic Acid Sensitivity of Triple-Negative Breast Cancer Cells Characterized by Constitutive Activation of the notch1 Pathway: The Role of Rarβ
por: Paroni, Gabriela, et al.
Publicado: (2020)

Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression
por: Centritto, Floriana, et al.
Publicado: (2015)

RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells
por: Gianni, Maurizio, et al.
Publicado: (2016)

Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
por: Terao, Mineko, et al.
Publicado: (2019)

Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
por: Terao, Mineko, et al.
Publicado: (2019)

Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer
por: Garattini, Enrico, et al.
Publicado: (2016)

S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia
por: Gianni, Maurizio, et al.
Publicado: (2018)

Correction: S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia
por: Gianni, Maurizio, et al.
Publicado: (2022)

Retinoids and breast cancer: new clues to increase their activity and selectivity
por: Garattini, Enrico, et al.
Publicado: (2012)

Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas-based technology
por: Umbach, Alessandro, et al.
Publicado: (2022)

The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients
por: Bolis, Marco, et al.
Publicado: (2019)

Generation of a new mouse model of glaucoma characterized by reduced expression of the AP-2β and AP-2δ proteins
por: Barzago, Maria Monica, et al.
Publicado: (2017)

The mammalian aldehyde oxidase gene family
por: Garattini, Enrico, et al.
Publicado: (2009)

Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice
por: Dri, Arianna, et al.
Publicado: (2022)

Different Stability and Proteasome-Mediated Degradation Rate of SMN Protein Isoforms
por: Locatelli, Denise, et al.
Publicado: (2015)

Human Axonal Survival of Motor Neuron (a-SMN) Protein Stimulates Axon Growth, Cell Motility, C-C Motif Ligand 2 (CCL2), and Insulin-like Growth Factor-1 (IGF1) Production
por: Locatelli, Denise, et al.
Publicado: (2012)

Mouse aldehyde-oxidase-4 controls diurnal rhythms, fat deposition and locomotor activity
por: Terao, Mineko, et al.
Publicado: (2016)

Site Directed Mutagenesis of Amino Acid Residues at the Active Site of Mouse Aldehyde Oxidase AOX1
por: Schumann, Silvia, et al.
Publicado: (2009)

The Italian NHS: What Lessons to Draw from COVID-19?
por: Garattini, Livio, et al.
Publicado: (2020)

Pharmaceutical Strategy for Europe: Reflections on Public Health-Driven Drug Development, Regulation, and Policies
por: Garattini, Silvio, et al.
Publicado: (2021)

More room for telemedicine after COVID-19: lessons for primary care?
por: Garattini, Livio, et al.
Publicado: (2020)

The Italian NHS at regional level: same in theory, different in practice
por: Garattini, Livio, et al.
Publicado: (2021)

Analysis of workload generated in the two years following first consultation by each new cancer patient: studying the past to plan the future of cancer care
por: Garattini, SK., et al.
Publicado: (2022)

Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium
por: Nobili, Alessandro, et al.
Publicado: (2011)

Massive NGS data analysis reveals hundreds of potential novel gene fusions in human cell lines
por: Gioiosa, Silvia, et al.
Publicado: (2018)

Patient Organizations’ Funding from Pharmaceutical Companies: Is Disclosure Clear, Complete and Accessible to the Public? An Italian Survey
por: Colombo, Cinzia, et al.
Publicado: (2012)

Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Garattini, Silvio Ken, et al.
Publicado: (2021)

What to do in an oncology department to face the new COVID-19 era challenges?
por: Garattini, S. K., et al.
Publicado: (2020)

Switching Among Biosimilars: A Review of Clinical Evidence
por: Allocati, Eleonora, et al.
Publicado: (2022)

Pseudo-resistance to anticancer drugs
por: Davoli, Enrico, et al.
Publicado: (2022)

Hospital Pharmacists in Europe: Between Warehouse and Prescription Pad?
por: Garattini, Livio, et al.
Publicado: (2018)

Precision medicine and monoclonal antibodies: breach of promise?
por: Garattini, Livio, et al.
Publicado: (2019)

Pharmaceutical Patents in Europe: Radical Reforms Rather Than Getting Rid?
por: Garattini, Livio, et al.
Publicado: (2021)

Molecular classifications of gastric cancers: Novel insights and possible future applications
por: Garattini, Silvio Ken, et al.
Publicado: (2017)

The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer
por: Lisanti, Camilla, et al.
Publicado: (2022)

Pharmacokinetics of All‐trans Retinoic Acid in Pediatric Patients with Leukemia
por: Takitani, Kimitaka, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_g6jbvhsltl7unnfk4nfgdk1cu2